Prasugrel (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Prasugrel drug offered from Mylan Pharmaceuticals Inc.. This Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Prasugrel |
| SUBSTANCE NAME: | PRASUGREL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-15 |
| END MARKETING DATE: | 0000-00-00 |
Prasugrel HUMAN PRESCRIPTION DRUG Details:
| Item Description | Prasugrel from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2017-08-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-5185_41a4e332-6725-4cb7-940a-8291cf56cfe4 |
| PRODUCT NDC: | 0378-5185 |
| APPLICATION NUMBER: | ANDA205927 |
Other PRASUGREL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
